Establishment and Validation of an In Vitro Screening Method for Traditional Chinese Medicine-Induced Nephrotoxicity

Table 3

The medicines that were evaluated.

Number	Component name	Purchased from
Positive medicines	Aristolochic acid	Zhongxin Innova®, China
	Cyclosporine A	Gene Operation, USA
	Cisplatin	Sigma, USA
1	Cantharidin	Zhongxin Innova, China
2	Diosbulbin B	Zhongxin Innova, China
3	Sophocarpine	Zhongxin Innova, China
4	Triptonide	Zhongxin Innova, China
5	Cnidium lactone	Zhongxin Innova, China
6	2,4-acetyl alisma alcohol A	Zhongxin Innova, China
7	2,3-acetyl alisma alcohol B	Zhongxin Innova, China
8	Mesaconitine	Zhongxin Innova, China
9	Hypaconitine	Zhongxin Innova, China
10	Tripterine	Zhongxin Innova, China
11	Triptolide	Zhongxin Innova, China
12	Evodiamine	Zhongxin Innova, China
13	Rutaecarpine	Zhongxin Innova, China
14	Periplocin	Zhongxin Innova, China
15	Periplocymarin	Zhongxin Innova, China
16	Periplogenin	Zhongxin Innova, China
17	Emodin	Zhongxin Innova, China
18	Rhein	Zhongxin Innova, China